Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

P. Polack, Fernando; J. Thomas, Stephen; Kitchin, Nicholas; Absalon, Judith; Gurtman, Alejandra; Lockhart, Stephen; L. Perez, John; Pérez Marc, Gonzalo; Duarte Moreira, Edson; A. F. Zerbini, Cristiano; Bailey, Ruth; A. Swanson, Kena; Roychoudhury, Satrajit; Koury, Kenneth; Li, Ping; V. Kalina, Warren; Cooper, David; W. Frenck, Robert; L Hammitt, Laura; Türeci, Özlem; Nell, Haylene; Schaefer, Axel; Ünal, Serhat; B Tresnan, Dina; Mather, Susan; R. Dormitzer, Philip; Şahin, Uğur; U. Jansen, Kathrin; C. Gruber, William

doi:10.1056/nejmoa2034577

Public

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Published in New England Journal of Medicine • Dec 10, 2020

Authors:

Fernando P. Polack

Stephen J. Thomas

Nicholas Kitchin

Abstract

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic. Safe and effective vaccines are needed urgently. METHODS: In an ongoing multinational, placebo-c...

Subject

Coronavirus disease 2019 (COVID-19)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

2019-20 coronavirus outbreak

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!